Spine Innovation
Former entity
A medical technology startup developing advanced 3D-printed titanium spinal interbody systems designed to optimize bone ingrowth and surgical outcomes.
- Team Size
- 1-10
- Stage
- Active
- Total Funding
- $1.34M
- Latest Round
- Seed
- Key Investors
- Private Investors
Technology & Products
Key Products
LOGIC™ Titanium Expandable Interbody System, incorporating OsteoSync™ Ti, a patented, pure titanium lattice material.
Technological Advantage
Leverages advanced Metal Additive Manufacturing (3D printing) to create complex geometries impossible via traditional machining, combined with an expandable mechanism that allows for minimally invasive insertion and customized disc height restoration.
Differentiation
Value Proposition
Improves spinal fusion success rates by utilizing a proprietary 3D-printed architecture that mimics natural bone structure, providing immediate mechanical stability and long-term osseointegration.
How They Differentiate
Utilizes a proprietary 'Truss-Grid' 3D-printed architecture that optimizes the balance between high-porosity for bone ingrowth and high structural integrity for mechanical stability.
Market & Competition
Target Customers
Orthopedic surgeons, neurosurgeons, hospitals, and ambulatory surgery centers (ASCs).
Industry Verticals
Medical Devices, Healthcare, Spine Surgery, Additive Manufacturing
Competitors
4WEB Medical; Camber Spine; Alphatec Spine (ATEC)
Growth & Milestones
Growth Metrics
Transitioning from regulatory approval phase to commercial launch; expanded product portfolio from static to expandable implants within 12 months.
Major Milestones
Founded in 2013 in collaboration with surgeon inventors from Scripps Health, San Diego, CA, Received FDA 510(k) clearance (K232433) for the LOGIC™ Titanium Implant System in 2024, Received FDA 510(k) clearance for the LOGIC™ Titanium Expandable Interbody System in January 2026
Notable Customers
Orthopedic Surgeons; Neurosurgeons; Ambulatory Surgery Centers (ASCs)
Funding rounds
- SeedUndisclosed2022-01Lead: N/A · Source: Reference 2